12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga·09/04/2025 17:05:59
Listen to the news
Gainers
- Bone Biologics (NASDAQ:BBLG) stock moved upwards by 38.2% to $2.86 during Thursday's regular session. The market value of their outstanding shares is at $3.3 million.
- NovaBay Pharmaceuticals (AMEX:NBY) shares increased by 34.32% to $3.6. The market value of their outstanding shares is at $15.6 million.
- Aquestive Therapeutics (NASDAQ:AQST) stock moved upwards by 22.4% to $4.83. The market value of their outstanding shares is at $477.8 million.
- Rein Therapeutics (NASDAQ:RNTX) stock increased by 15.87% to $1.46. The market value of their outstanding shares is at $27.9 million.
- AquaBounty Techs (NASDAQ:AQB) stock rose 15.26% to $1.35. The company's market cap stands at $4.5 million.
- Nektar Therapeutics (NASDAQ:NKTR) shares moved upwards by 14.57% to $32.71. The company's market cap stands at $542.9 million.
Losers
- Artelo Biosciences (NASDAQ:ARTL) shares decreased by 50.8% to $4.31 during Thursday's regular session. The market value of their outstanding shares is at $11.5 million.
- Aethlon Medical (NASDAQ:AEMD) shares fell 45.38% to $0.74. The market value of their outstanding shares is at $3.5 million.
- Purple Biotech (NASDAQ:PPBT) shares decreased by 42.61% to $0.81. The market value of their outstanding shares is at $3.7 million.
- ImageneBio (NASDAQ:IMA) shares declined by 30.81% to $9.49. The company's market cap stands at $153.3 million.
- Sharps Technology (NASDAQ:STSS) stock decreased by 23.09% to $9.16. The market value of their outstanding shares is at $12.1 million.
- Zhengye Biotechnology (NASDAQ:ZYBT) shares decreased by 18.77% to $7.92. The market value of their outstanding shares is at $462.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.